SPC348
Dostarlímab
Status:
VeittApplication date:
3.9.2021Application published:
15.9.2020Grant published:
15.7.2023
Max expiry date:
21.4.2036Medicine name:
JemperliMedicine for children:
No
Timeline
Today
15.9.2020Publication
3.9.2021Application
15.7.2023Registration
21.4.2036Expires
Marketing license
IS authorization number:
EU/1/21/1538/001Date:
12.5.2021
Foreign authorization number:
EU/1/21/1538Date:
21.4.2021
Owner
Name:
AnaptysBio, Inc.Address:
10770 Waterbridge Circle, Suite 210, San Diego, CA US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2992017